COVID-19

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to…

8 months ago

Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results

ATLANTA, GA, April 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB:…

8 months ago

Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education

SINGAPORE, April 11, 2025 /PRNewswire/ -- Duke-NUS Medical School has appointed Professor Patrick Tan as its next and fourth Dean, effective…

9 months ago

Scilex Holding Company Announces 1-for-35 Reverse Stock Split

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating…

9 months ago

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing…

9 months ago

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting…

9 months ago

Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation

- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected to cover the entire…

9 months ago

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in…

9 months ago

Mars Veterinary Health Underscores Long-Term Commitment to Research & Innovation in Groundbreaking Science Impact Report

Global leader in peer-reviewed veterinary research highlights progress in advancing veterinary science and clinical excellence through inaugural science report launch…

9 months ago

GAIA Study Reveals Groundbreaking Links Between Nutrition, Mental Resilience, and Infectious Disease Recovery

New Research Highlights the Power of Whole Foods Plant-Based Diets in Burnout Reduction and COVID-19 Recovery BOSTON, April 3, 2025…

9 months ago